The Cardiovascular Research Foundation of Southern California serves as the non-profit research arm of the Cardiovascular Medical Group of Southern California. Established to support and conduct critical research, the foundation focuses on innovative approaches to improve the diagnosis and treatment of cardiovascular diseases, funded primarily through independent donations.
2006
20-4100028
$2.376 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Explore ongoing research studies addressing various cardiovascular conditions.
Highlights of our recent breakthroughs in cardiovascular treatment.
Learn about our philanthropic efforts and how you can contribute.
Introduction of PCSK9 Injectable Medications
Pioneered new medications for the treatment and prevention of coronary artery disease.
Non-Invasive Coronary Angiography
First to use non-invasive coronary computed tomography angiography to measure coronary artery blood flow.
Early Detection of Plaque in Coronary Arteries
Demonstrated that plaque can start as early as 20 years of age and can be managed with appropriate therapy.
Overall Score
53
68
/100
Program Expense Ratio
70.85%
8
/20
Program Revenue Growth
698.36%
20
/20
Leverage Ratio
0.0007969
20
/20
Working Capital Ratio
3.875
18
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 320.9K | 57.37% |
Program Services | 193.9K | 34.67% |
Investment Income | 43.28K | 7.74% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 1.258K | 0.22% |
Total Revenue | 559.4K | 100.00% |
Philanthropy
Operating FoundationsPhilanthropy
Operating FoundationsPhilanthropy
Operating FoundationsPhilanthropy
Operating FoundationsPhilanthropy
Operating Foundations